Dominant sellers send Novo Nordisk stock lower in technical pullback

Traders Union
All News
Financial News
Novo Nordisk drops 2.63% to $42.91

All news

Editors' Picks

Crypto News

Financial News

Market Voices

Billionaires

Companies

Broker News

Regulators News

Parshwa Turakhiya

Yesterday

Dominant sellers send Novo Nordisk stock lower in technical pullback — Novo Nordisk drops 2.63% to $42.91

Novo Nordisk (NVO) stock is trading at $42.91 following a daily decline of 2.63%. The price currently sits below its key moving averages, reflecting downward momentum on the session.

NVO price prediction

24H 0.68%

$44.36

48H 0.7%

$44.37

7D 5.02%

$46.27

1M 7.51%

$47.37

3M -28.73%

$31.4

6M -27.44%

$31.97

12M -35.16%

$28.57

Detailed

Current price: $ 44.06 2.06 4.89%

Real-time Data 12:18

Daily range 43.32

44.37

Weekly range 41.91

45.89

Highlights

Novo Nordisk's treasury holdings reached 35,074,480 B shares after consistent buybacks since February, shrinking the free float significantly.
First quarter 2026 earnings per share of $1.04 beat consensus, underscoring robust operating fundamentals amid recent stock sell pressure.
Technical signals imply persistent short- and long-term downward momentum, with expected price consolidation in the $41.00 to $44.50 range and low probability of a sustained rebound.

Share repurchases and earnings strength amid continued supply pressure

Novo Nordisk holds 35,074,480 B shares as treasury stock as of June 2, 2026, reflecting a sustained effort to reduce the outstanding share float and potentially moderate supply-driven pressure on the stock. The company has executed significant share repurchases since February 4, 2026, acquiring 17,889,179 B shares at an average price of DKK 263.47, and continued these activities with an additional 840,151 B shares bought in late May. Earlier, Novo Nordisk reported first quarter 2026 earnings per share of $1.04, exceeding analyst expectations and demonstrating fundamental strength, though price action has remained under broader selling pressure.

Mixed momentum as price nears resistance following oversold signals

NVO is trading below the MA-20 ($45.16) and MA-200 ($48.89), while remaining just above the MA-50 ($41.38). The daily Ichimoku Kijun level stands at $43.75, now acting as immediate resistance. Momentum signals are mixed, with MACD showing strong buy momentum but ADX pointing to a lack of clear trend direction. RSI remains subdued due to persistent selling pressure; both CCI and Stoch RSI indicate oversold conditions. BBP is negative and classified as oversold, highlighting seller dominance through the session. A daily price gap down from $44.07 to an open at $43.49, then to $42.91, leaves price near the lower end of today’s $42.25–$43.63 range amid ongoing moderate volatility. The Awesome Oscillator remains neutral, while the divergence between MACD and oscillators suggests a complex technical setup.

Limited upside as low probability favors sideways consolidation

Over the next five trading days, the expected price volatility band is $41.00 to $44.50 around current levels. The probability of an upward move remains low (less than 20%), and the baseline scenario points to sideways consolidation within this range. A break above resistance at $43.75 and subsequent strength through $44.50 would trigger a bullish reversal. If NVO slips below $42.25, downside momentum could accelerate toward the $41.00 area or lower.

Anton Kharitonov, expert at Traders Union, notes Novo Nordisk is still under strong technical pressure despite robust buybacks and a recent earnings beat. He sees the stock consolidating below key moving averages, with oversold signals yet to trigger a reversal. The probability of sustained recovery remains low unless resistance at $43.75 is reclaimed. "Until price breaks above immediate resistance, any bounce is likely to be short-lived and defensive positioning remains justified."

Earlier, analysts noted that Novo Nordisk shares were under persistent downside pressure despite strong buyback activity and solid financial results. The current technical setup maintains this cautious outlook, with oversold momentum signals and limited probabilities of an immediate rebound, making $41.00 to $44.50 the key range for traders to monitor in the coming sessions.

Source of Data: NVO Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.